Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
about
The path for metal complexes to a DNA targetDirect delivery of a cytotoxic anticancer agent into the metastatic lymph node using nano/microbubbles and ultrasound.Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cellsDihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.Resistance to platinum-based chemotherapy in lung cancer cell lines.Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.Modulation of cisplatin cytotoxicity by sulphasalazineInduction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changesModulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells.Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluationSynergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cellsContrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes.Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.Comparison of the cytotoxic effects of Juniperus sabina and Zataria multiflora extracts with Taxus baccata extract and Cisplatin on normal and cancer cell lines.Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.Increased efficiency of cisplatin-resistant cell lines to DNA-mediated gene transfer with cationic liposome.Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.Cellular accumulation of the anticancer agent cisplatin: a review.Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells.The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.Reduction of cellular cisplatin resistance by hyperthermia--a review.Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.Differential Na+,K(+)-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras.Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin.Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C.Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategy.Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines.
P2860
Q26999667-62206EEC-71B4-40F4-9BD6-0B0E2C59507EQ28546612-AA396FB2-3E3F-4D38-8B40-D0E4A6F70F12Q33307000-E5A56FBF-AF5F-4172-B74B-FA1B0266951DQ33755882-B575E35C-3B3D-4F32-82AE-5F1B03C712BAQ34214006-BFCA957D-0D12-4EF8-8BAB-970FA359E246Q34625375-31771E59-F5FD-40D1-A1FC-612E12BD4C74Q34721854-41A7E85B-86F4-4497-A0AA-E1FBD1A0E8EDQ35553372-165E1A1D-FF15-4ADE-95BA-6ADA5E6FA3B3Q36079955-133444B1-F3B7-4DF0-B9B5-5FDD6BB82DB1Q36080620-5517F91E-892A-4691-8923-489FC752E407Q36080744-FC3CDA2F-4A12-45C4-8598-19E47A325712Q36136501-CD458045-0AB0-4B2A-807E-208634CFA0BCQ36211730-AD4246C0-4045-4820-B3D1-CCEFC35F821CQ36566743-A58280CC-10B5-4517-AA2D-B1AF82351B06Q36753313-99D5BCFF-9CEC-464A-9BA1-FC69B41BD4DBQ38958264-C6E89627-CFF4-47F7-83E1-8CBCFDE62E14Q39247606-8467B6FA-FE61-4435-9F76-75B2C4DB1585Q39448599-2F483FC4-65C9-4274-8515-E7B50FEC681DQ39674090-D2CA8843-6D59-4C12-B20F-E200A59B36AFQ39764720-D487734E-97CD-4007-8063-4ECB4A374F75Q40370558-1CE740C1-E406-4F72-A6B9-353C5B22A5D5Q40697952-EFAC39D3-99F5-4997-8079-DF4F88FDDA39Q40751233-1B234599-749E-4C4F-8F0E-A0D5BB4E7E56Q40796113-748A0E9A-030D-4960-AFD3-63BD41DCA952Q40836377-1778F3EB-D061-455D-85D2-085B59E56BB2Q40917698-C68EE348-35CC-4726-9F97-9227488F3B77Q41229180-1897C9F2-F3EE-4AC2-B4A5-6F25DFEE9C60Q41254059-86A49B7A-5422-41B8-86FF-FFB231E51E65Q41282079-F0AFDB09-CC97-4B3A-9F85-4013B7E1C0C8Q41285872-C8D428C0-86F1-4F81-8C73-1990DAD8A16EQ41311155-522F86DD-3517-4CAD-B394-64D614295799Q41631033-60858503-61BB-4730-BE1E-D299023655F8Q42590265-FF43232B-ACF0-40E1-9940-A82FD0E20EB8Q42834141-102F6120-11BE-40CD-9E91-9F469AD6ECF6Q43157204-9C65D23D-1521-4FCC-99B3-EE1AA7EA363DQ44222827-3E27A78B-F73A-411A-A56E-88EF39C2DF1FQ44836102-AFD952E6-5D0E-411A-8F02-ABD17293EAF0Q45866859-97CDC064-4C9C-4BF1-AC46-1C15F3FC774BQ48163236-92EED14C-806C-4921-AA35-447C12496469Q54172399-4607D396-D481-48F3-B902-1B8F7D0F87C5
P2860
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@ast
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@en
type
label
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@ast
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@en
prefLabel
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@ast
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@en
P2093
P2860
P356
P1476
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
@en
P2093
Timmer-Bosscha H
de Vries EG
P2860
P2888
P304
P356
10.1038/BJC.1992.249
P407
P577
1992-08-01T00:00:00Z